ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

60 Minutes: Boston Scientific Vaginal Mesh Unfit for Humans


Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Woman in hospital bed wearing gown

Boston Scientific knowingly used unstable plastic in its vaginal mesh implants. The implants led to injuries in thousands of women, according to a 60 Minutes report broadcast on May 13, 2018.

Surgeons use Boston Scientific’s mesh implants to treat incontinence and pelvic organ prolapse in women.

The rate of complications caused by transvaginal mesh is so high the U.S. Food and Drug Administration classifies them as Class III devices. This category is for the riskiest devices approved by the agency.

Mesh victim Tammy Jackson has suffered complications from mesh for nearly a decade. She appreciates the 60 Minutes coverage.

Jackson told her mesh story in the upcoming 2018 Netflix documentary called The Bleeding Edge.

“60 Minutes brought some awareness,” Jackson told Drugwatch about the report. “I would have liked to hear more about the complications and deaths of mesh patients. Like being septic, antibiotic resistant, kidney atrophy and kidney stones — all of which I am suffering.”

Jackson is currently in the hospital for mesh complications. She and other women filed lawsuits claiming the implants are defective.

Part of the defect may lie in the plastic used to make the implants, according to experts.

Polypropylene Mesh is ‘Unstable’

Manufacturers make the implants from a plastic called polypropylene. Polypropylene is unstable when exposed to oxygen, plastics engineer Duane Priddy told 60 Minutes.

Priddy has testified in lawsuits against Boston Scientific.

“I can’t in my wildest imagination imagine anybody that’s knowledgeable in the science of plastics ever deciding that it was appropriate to use polypropylene in the human body,” Priddy said. “It’s well known that it’s oxidatively unstable.”

Despite concerns from experts, mesh was too profitable for Boston Scientific to stop manufacturing.

Boston Scientific Used Counterfeit Chinese Plastic in Mesh

In 2004, plastic maker Chevron Phillips told Boston Scientific it would no longer supply Marlex polypropylene plastic for the implants.

“We are simply not interested in this business at any price,” Chevron Phillips told Boston Scientific.

Injured by complications related to transvaginal mesh? Get a Free Case Review

Marlex should not be used for “permanent implantation in the human body,” Chevron Phillips warned.

This didn’t stop Boston Scientific from making the implants. Instead, it smuggled counterfeit Marlex plastic from a supplier in China called Emai.

Boston Scientific’s tests found several inconsistencies in the plastics. It used the plastic anyway.

Priddy told 60 Minutes this plastic would only last a few months in the human body.

Dr. Tom Margolis has removed problematic Boston Scientific mesh implants from women. He describes using the Chinese plastic as “human experimentation but without consent.”

“We don’t know how this affects humans,” Margolis told 60 Minutes. “It’s never been tested before.”

Boston Scientific faces lawsuits under the Racketeer Influenced and Corrupt Organizations Act (RICO) over its alleged illegal use of counterfeit plastic.

Other Companies Involved in Mesh Controversy

The 60 Minutes report focuses on Boston Scientific. But, a handful of other companies also make vaginal mesh with polypropylene. Companies in lawsuits include Boston Scientific, C.R. Bard and Johnson & Johnson’s Ethicon subsidiary.

C.R. Bard also used Chevron Phillips’ Marlex plastic.

Chevron Phillips also told Bard not to use its plastic for human implantation, according court documents. Mesh lawsuits against Bard say the company tried to cover up its use of Marlex.

At one time, more than 100,000 women filed federal personal injury lawsuits against pelvic mesh makers.

In April 2018, Boston Scientific told investors it put aside $800 million to settle its remaining mesh lawsuits.

Despite thousands of lawsuits over its mesh, Boston Scientific stands by its product.

“Nearly one million women have been successfully treated… We have extensively tested the [plastic] resin to confirm its composition, safety and performance,” the company told 60 Minutes.

Michelle Llamas, Senior Content Writer
Written By Michelle Llamas Senior Writer

Michelle Llamas has been writing articles and producing podcasts about drugs, medical devices and the FDA for nearly a decade. She focuses on various medical conditions, health policy, COVID-19, LGBTQ health, mental health and women’s health issues. Michelle collaborates with experts, including board-certified doctors, patients and advocates, to provide trusted health information to the public. Some of her qualifications include:

  • Member of American Medical Writers Association (AMWA) and former Engage Committee and Membership Committee member
  • Centers for Disease Control and Prevention (CDC) Health Literacy certificates
  • Original works published or cited in The Lancet, British Journal of Clinical Pharmacology and the Journal for Palliative Medicine
Edited By
Emily Miller
Emily Miller Managing Editor

2 Cited Research Articles writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

  1. 60 Minutes. (2018, May 13). Gynecological mesh: The medical device that has 100,000 women suing. Retrieved from
  2. Carlson, J. (2018, April 25). Boston Scientific beats estimates in first quarter, increases 2018 guidance. Retrieved from
View All Sources
Call to speak with a legal expert
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's sponsors support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our sponsors page.

(877) 312-3413